Kirkland Reps Baxter International In $380M Baxa Buy

Law360, New York (August 25, 2011, 12:25 PM ET) -- Baxter International Inc. announced Thursday that it had reached an agreement to purchase Baxa Corp., which develops oral and intravenous drug delivery systems, for $380 million.

Baxter said that accounting and other expenses for the all-cash transaction would cause a temporary drag of 3 to 5 cents per share on its fiscal 2012 earnings, but that the deal would be a net boon to its share price in 2013 and beyond.

Englewood, Colo.-based Baxa specializes in products that improve the efficiency and accuracy of IV and...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers